Vitalgenics Inc.

Excindogen treats and cures solid tumor cancers. Preclinical studies conducted at MD Anderson Cancer Center. Lead disease Pancreatic Cancer. Dissolves Tumors.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Castle Rock, CO, USA
  • Currency USD
  • Founded June 2018
  • Employees 2
  • Incorporation Type C-corp
  • Website vitalgenics.co

Company Summary

Vitalgenics Inc. has unraveled the mystery of the biological pathway of solid tumors cancers. Our lead compound Excindogen has been proven to dissolve tumors in preclinical studies performed at MD Anderson Cancer Center and in a case study of 4th stage melanoma in a 79 year old male with 25 of 30 tumors dissolving and the last 5 including lymph node tumor becoming inactive. Cancer free for 1 year, no new tumors have developed.

Team

  • Charles Owen is an applied scientist focused on solid tumor cancers , cell mediated immunity , clear understanding of the cell mediated immune stress response cascade, Ca2+, the inflammatory response and how these relate to solid tumor cancers. Mr. Owen is experienced in research and development, clinical study protocols, toxicity studies, target therapy drug delivery applications. 2 patents granted.

  • Joey Edge
    CEO

    has had a very successful career as an innovative leader. He is focused on achieving positive results through strong
    leadership, effective communication, interpersonal relations, and excellent analytical skills. His successes have been the result of disrupting the status quo and revolutionizing normal thinking and processes. His innovative and pragmatic approach has led to developing strategic
    partnerships and synergies.

  • Dr. Douglas Coldwell
    Chief Scientific Officer

    is an internationally recognized expert in local regional therapy of cancer. He has pioneered numerous treatments for cancer. . Dr. Coldwell is a Fellow of the Society of Interventional Radiology, the American College of Radiology, a the American Heart Association. He has been on numerous university faculties, frequently lectures internationally, and has authored over100 peer reviewed papers.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free